<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: B Lymphocyte Stimulator (BLyS) protein and its receptor are new members of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor family, with specific effects exclusively on B cells </plain></SENT>
<SENT sid="1" pm="."><plain>We have studied the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell expression of the BLyS-Receptor (BLyS-R) and the serum BLyS protein levels in patients with different types of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: BLyS-R expression was assessed by flow cytometry on B cells from 43 NHL patients and 10 <z:mpath ids='MPATH_458'>normal</z:mpath> donors </plain></SENT>
<SENT sid="3" pm="."><plain>BLyS protein serum levels were analyzed by ELISA </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> B cells, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath>, expressed BLyS-R </plain></SENT>
<SENT sid="5" pm="."><plain>The mean fluorescence intensity (MFI +/- SD) of BLyS-R on <z:mpath ids='MPATH_458'>normal</z:mpath> B cells was 25.2 +/- 2.3 arbitrary units, while follicular NHL and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) exhibited significantly lower expression of the BLyS-R (17.7 +/- 3.1; 15.5 +/- 3.9, respectively, p &lt; 0.0001 for both); other <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes expressed levels comparable to <z:mpath ids='MPATH_458'>normal</z:mpath> B cells (diffuse large cell, 24.8 +/- 4.3; mantle cell, 20 +/- 4.7; marginal zone, 20.7 +/- 3.7) </plain></SENT>
<SENT sid="6" pm="."><plain>BLyS protein serum levels were analyzed in 15 <z:mpath ids='MPATH_458'>normal</z:mpath> donors and 17 patients with follicular NHL </plain></SENT>
<SENT sid="7" pm="."><plain>Levels of BLyS protein were, on average, threefold higher in patients with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> compared to <z:mpath ids='MPATH_458'>normal</z:mpath> donors (mean +/- SD; 13.4 +/- 5.6 ng/mL vs 4.6 +/- 0.7 ng/mL; p &lt; 0.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>BLyS protein alone was unable to stimulate proliferation in cultures of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> B cells or <z:mpath ids='MPATH_458'>normal</z:mpath> B cells </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The specificity of the expression of BLyS-R by B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> opens new opportunities for the treatment of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> by targeting this ligand-receptor pair </plain></SENT>
</text></document>